# Clinical trials recruiting in Indiana: 1,294 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,294 trials recruiting or not yet recruiting with a site in Indiana, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Indiana: 1,294 rows for $64.70, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 26 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/indiana

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,294
- Recruiting or not yet: 1,294
- Read on: November 19, 2026

## Trials

The 25 newest of 1,294, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947186 | Early Feasibility Study of a Novel Male Contraceptive Device: Safety, Usability, and Acceptability Outcomes | Indiana University | Not applicable | Recruiting | Male Contraception, Contraceptive Device, Pregnancy Prevention, Prevention of Semen Exposure During Intercourse | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947186) |
| November 18, 2026 | NCT07946861 | Intramedullary Nailing for Femoral Shaft Fractures | Indiana University | Not applicable | Recruiting | Femoral Shaft Fracture | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946861) |
| November 13, 2026 | NCT07935356 | A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia | Sponsor not shown (see the record) | Phase 3 | Recruiting | Thrombasthenia | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935356) |
| November 10, 2026 | NCT07929506 | Prophylactic CPAP for Late Preterm Infants Born by C-Section to Reduce NICU Admission | Indiana University | Not applicable | Not yet recruiting | Late Preterm Infant | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929506) |
| November 10, 2026 | NCT07928219 | A Study of LY3981314 in Participants With Autoimmune Hepatitis | Eli Lilly and Company | Phase 1 | Not yet recruiting | Hepatitis Autoimmune Disease, Hepatitis | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928219) |
| November 6, 2026 | NCT07922772 | Days-Off Versus Daily Initial Peritoneal Dialysis Prescription | University of Michigan | Not applicable | Not yet recruiting | Kidney Failure | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922772) |
| November 6, 2026 | NCT07921459 | Mechanisms of Instrument-Assisted Soft Tissue Manipulation (IASTM) Force Dose-Response Effects in the Calf-Foot Region | Indiana University | Not applicable | Not yet recruiting | Limited Ankle Dorsiflexion Range of Motion, Calf Muscle Tightness | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07921459) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 2, 2026 | NCT07909499 | BD Onclarity HPV Assay on the BD COR Instrument: Self-collected Vaginal Swabs Validation | Indiana University | Not applicable | Not yet recruiting | Healthy Subjects, HPV | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909499) |
| October 29, 2026 | NCT07905183 | A Study of ELVN-001 Versus Investigator-Selected TKI, in CP-CML Previously Treated With One or More TKIs | Enliven Therapeutics | Phase 3 | Recruiting | Chronic Myeloid Leukemia (CML), Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive, Chronic Phase Chronic... | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07905183) |
| October 29, 2026 | NCT07903311 | Iron Repletion in Cystic Fibrosis | University of Michigan | Phase 4 | Not yet recruiting | Cystic Fibrosis, Iron Deficiencies, Iron Deficiency Diseases | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903311) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 27, 2026 | NCT07898995 | Clinical Performance and Outcomes After Toric Lens Transition | CooperVision International Limited (CVIL) | Not applicable | Not yet recruiting | Astigmatism | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898995) |
| October 26, 2026 | NCT07895381 | A Study to Describe Patient REal-world FitusiRan ExpeRience | Sanofi | Observational | Not yet recruiting | Hemophilia A or B | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895381) |
| October 22, 2026 | NCT07890610 | Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest | Children's Hospital of Philadelphia | Observational | Recruiting | Cardiac Arrest (CA) | 1,620 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890610) |
| October 22, 2026 | NCT07889232 | Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer | VA Office of Research and Development | Phase 1/2 | Not yet recruiting | Metastatic Non-Small Cell Lung Cancer, Cancer-Associated Weight Loss, Elevated Inflammatory Markers | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889232) |
| October 20, 2026 | NCT07882264 | Fiber Soda on Postprandial Risk Factors | Ball State University | Not applicable | Recruiting | Healthy Participants | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882264) |
| October 19, 2026 | NCT07881458 | A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881458) |
| October 19, 2026 | NCT07881432 | A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity | 2,115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881432) |
| October 19, 2026 | NCT07880470 | Is Splinting After Ulnar Nerve Transposition Necessary? | University of Chicago | Not applicable | Not yet recruiting | Ulnar Nerve Transposition | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880470) |
| October 15, 2026 | NCT07874815 | Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Pulmonary Disease, Chronic Obstructive | 2,136 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874815) |
| October 13, 2026 | NCT07871513 | A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With... | AbbVie | Phase 2 | Recruiting | Upper Facial Lines, Glabellar Lines | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871513) |
| October 9, 2026 | NCT07868939 | Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2) | Viking Therapeutics, Inc. | Phase 3 | Recruiting | Weight Loss | 560 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868939) |
| October 9, 2026 | NCT07868835 | Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) | Viking Therapeutics, Inc. | Phase 3 | Recruiting | Weight Loss | 560 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868835) |
| October 9, 2026 | NCT07867080 | A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME). | 4D Molecular Therapeutics | Phase 3 | Recruiting | Diabetic Macular Edema (DME) | 514 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867080) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Indiana University | Indianapolis | 117 |
| Riley Hospital for Children | Indianapolis | 64 |
| Indiana University School of Medicine | Indianapolis | 43 |
| Indiana University/Melvin and Bren Simon Cancer Center | Indianapolis | 38 |
| Reid Health | Richmond | 36 |
| UChicago Medicine Northwest Indiana | Crown Point | 33 |
| Northwest Oncology LLC | Dyer | 31 |
| Saint Mary Medical Center | Hobart | 31 |
| The Community Hospital | Munster | 31 |
| Northwest Cancer Center - Valparaiso | Valparaiso | 30 |
| Women's Diagnostic Center - Munster | Munster | 29 |
| Northwest Cancer Center - Crown Point | Crown Point | 27 |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | 27 |
| IU Health North Hospital | Carmel | 27 |
| Northwest Cancer Center - Hobart | Hobart | 25 |
| Saint Catherine Hospital | Indianapolis | 25 |
| Indiana University Health | Indianapolis | 24 |
| Indiana University Health University Hospital | Indianapolis | 21 |
| Ascension Saint Vincent Indianapolis Hospital | Indianapolis | 18 |
| Community Health Network | Indianapolis | 17 |
| Franciscan Health Indianapolis | Indianapolis | 16 |
| IU Health Methodist Hospital | Indianapolis | 16 |
| Franciscan Health | Munster | 15 |
| Riley Children's Hospital | Indianapolis | 15 |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne | 15 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 3 |
| Phase 1 | 65 |
| Phase 1/2 | 62 |
| Phase 2 | 202 |
| Phase 2/3 | 42 |
| Phase 3 | 392 |
| Phase 4 | 40 |
| Not applicable | 279 |
| Observational | 209 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 55 |
| Neoplasms | 38 |
| Breast Neoplasms | 36 |
| Obesity | 35 |
| Heart Failure | 34 |
| Lung Neoplasms | 29 |
| Colorectal Neoplasms | 27 |
| Neoplasm Metastasis | 26 |
| Prostatic Neoplasms | 24 |
| Ovarian Neoplasms | 24 |
| Overweight | 23 |
| Cardiovascular Diseases | 22 |
| Multiple Myeloma | 20 |
| Diabetes Mellitus, Type 2 | 19 |
| Endometrial Neoplasms | 19 |
| Alzheimer Disease | 19 |
| Crohn Disease | 16 |
| Coronary Artery Disease | 16 |
| Squamous Cell Carcinoma of Head and Neck | 15 |
| Diabetes Mellitus, Type 1 | 15 |
| Urinary Bladder Neoplasms | 15 |
| Leukemia, Myeloid, Acute | 15 |
| Pancreatic Neoplasms | 15 |
| Hypertension | 14 |
| Melanoma | 14 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Indiana University | 155 |
| National Cancer Institute (NCI) | 49 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 43 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 37 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 23 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 22 |
| Children's Oncology Group | 21 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 20 |
| SWOG Cancer Research Network | 17 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 17 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 16 |
| NRG Oncology | 14 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 14 |
| VA Office of Research and Development | 14 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 14 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 13 |
| Alliance for Clinical Trials in Oncology | 13 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 12 |
| Purdue University | 12 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 11 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 10 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 10 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 8 |
| Duke University | 8 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 8 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Indiana

- [Metal fabricators in Indiana, United States](https://specstream.ai/data/businesses/metal-fabricators/indiana-united-states)
- [Junk removal companies in Indiana, United States](https://specstream.ai/data/businesses/junk-removal-companies/indiana-united-states)
- [Hospices in Indiana, United States](https://specstream.ai/data/businesses/hospices/indiana-united-states)
- [Financial services firms in Indiana, United States](https://specstream.ai/data/businesses/financial-services-firms/indiana-united-states)
- [Education services in Indiana, United States](https://specstream.ai/data/businesses/education-services/indiana-united-states)
- [Construction companies in Indiana, United States](https://specstream.ai/data/businesses/construction-companies/indiana-united-states)
